Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins

被引:56
作者
Lorentz, A
Schuppan, D
Gebert, A
Manns, MP
Bischoff, SC [1 ]
机构
[1] Hannover Med Sch, Dept Internal Med Gastroenterol, D-30623 Hannover, Germany
[2] Hannover Med Sch, Dept Anat, D-30623 Hannover, Germany
[3] Univ Erlangen Nurnberg, Dept Med 2, Erlangen, Germany
关键词
D O I
10.1182/blood.V99.3.966
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mast cells are Inflammatory and immunoregulatory cells resident in tissues. They develop from bone marrow-derived progenitor cells that enter the tissue through the blood circulation. The specific localization and migration of mast cells in tissues is dependent on their interaction with extracellular matrix (ECM) proteins. Adhesion of human mast cells isolated from intestinal mucosa and cultured in the presence of stem cell factor (SCF) to ECM proteins is analyzed. It was observed that SCF is a unique cytokine enhancing mast cell adhesion to all tested ECM proteins (fibronectin, laminin, collagen I, III, IV, VI, XIV) up to 5-fold, particularly to fibronectin (54% +/- 12% of mast cells) and to denatured collagens (40% +/- 12% on cyanogen bromide-cleaved peptides of collagen 1). Most noteworthy, preculture of mast cells with interleukin-4 (IL-4), in addition to SCIF, reduced their potency to adhere to ECM proteins to one third compared to mast cells cultured with SCIF alone. Mast cell adhesion was preferentially mediated by beta1 integrins, and most cells expressed the ECM-binding integrins alpha2beta1, alpha3beta1, alpha4beta1, alpha5beta1, and alphaVbeta3. SCF-Induced mast cell adhesion was totally blocked by wortmannin and apigenin, indicating an involvement of phosphatidylinositol 3-kinase and mitogen-activated protein kinase, and it was related to an up-regulation of the HUTS-21 beta1 epitope, which is associated with an activated conformation of beta1. In conclusion, these data indicate that SCIF induces the adhesion of cultured mast cells to ECM proteins, whereas IL-4 may promote detachment from the ECM. . (C) 2002 by The American Society of Hematology.
引用
收藏
页码:966 / 972
页数:7
相关论文
共 42 条
  • [1] IL-4 enhances proliferation and mediator release in mature human mast cells
    Bischoff, SC
    Sellge, G
    Lorentz, A
    Sebald, W
    Raab, R
    Manns, MP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) : 8080 - 8085
  • [2] C-KIT LIGAND - A UNIQUE POTENTIATOR OF MEDIATOR RELEASE BY HUMAN LUNG MAST-CELLS
    BISCHOFF, SC
    DAHINDEN, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) : 237 - 244
  • [3] Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls
    Bischoff, SC
    Schwengberg, S
    Wordelmann, K
    Weimann, A
    Raab, R
    Manns, MP
    [J]. GUT, 1996, 38 (01) : 104 - 114
  • [4] Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease
    Bischoff, SC
    Wedemeyer, J
    Herrmann, A
    Meier, PN
    Trautwein, C
    Cetin, Y
    Maschek, H
    Stolte, M
    Gebel, M
    Manns, MP
    [J]. HISTOPATHOLOGY, 1996, 28 (01) : 1 - 13
  • [5] Bischoff SC, 1997, J IMMUNOL, V159, P5560
  • [6] HUMAN PERIPHERAL-BLOOD BASOPHILS PRIMED BY INTERLEUKIN-3 (IL-3) PRODUCE IL-4 IN RESPONSE TO IMMUNOGLOBULIN-E-RECEPTOR STIMULATION
    BRUNNER, T
    HEUSSER, CH
    DAHINDEN, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) : 605 - 611
  • [7] COLUMBO M, 1995, J IMMUNOL, V154, P6058
  • [8] DASTYCH J, 1994, J IMMUNOL, V152, P213
  • [9] DVORAK AM, 1978, LANCET, V1, P498
  • [10] IDENTIFICATION OF MUTATIONS IN THE CODING SEQUENCE OF THE PROTOONCOGENE C-KIT IN A HUMAN MAST-CELL LEUKEMIA-CELL LINE CAUSING LIGAND-INDEPENDENT ACTIVATION OF C-KIT PRODUCT
    FURITSU, T
    TSUJIMURA, T
    TONO, T
    IKEDA, H
    KITAYAMA, H
    KOSHIMIZU, U
    SUGAHARA, H
    BUTTERFIELD, JH
    ASHMAN, LK
    KANAYAMA, Y
    MATSUZAWA, Y
    KITAMURA, Y
    KANAKURA, Y
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) : 1736 - 1744